Search

Search Constraints

You searched for: Author/Creator Faber, K N

Search Results

2. DOP46 Mucosal host-microbe interactions associate with clinical phenotypes in Inflammatory Bowel Disease. (30th January 2023)

3. DOP53 In-depth characterisation of the serum antibody epitope repertoire in Inflammatory Bowel Disease by high-throughput phage-displayed immunoprecipitation sequencing. (21st January 2022)

4. OP39 The effect of phenotype and genotype on the plasma proteome in patients with Inflammatory Bowel Disease. (27th May 2021)

5. P076 Patients with Inflammatory Bowel Disease show IgG immune responses towards disease-associated small intestinal bacteria. (21st January 2022)

7. P100 Atypical Anti-Neutrophil Cytoplasmatic Antibodies Are Antibodies Against Neutrophil Extracellular Traps: A Novel Pathophysiological Mechanism In Ulcerative Colitis. (30th January 2023)

8. P123 Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn's disease. (27th May 2021)

9. P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease. (21st January 2022)

10. P166 A combined set of four serum inflammatory biomarkers reliably predicts endoscopic disease activity in inflammatory bowel disease. (25th January 2019)